newsfilter
← Latest News
Business Wire·

Appili Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

Appili Therapeutics Inc. (TSX:APLI, OTCQX:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases, today announced that Stéphane Paquette, Vice President, Corporate Development, will present a